ConductScience.org, home

Paper4569508

Immunosuppression--agents, procedures, speculations and prognosis.

Camiener GW and 1 other. Prog Drug Res, 1972. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Immunosuppression--agents, procedures, speculations and prognosis. Papers, record 4569508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4569508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunosuppression--agents, procedures, speculations and prognosis.
PubMed
Journal
Prog Drug Res
PubMed
Year
1972
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Camiener GWG W
2Wechter WJW J

Source PubMed

Download CSV of authors

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppression TherapyMajor topic
Immunosuppressive AgentsMajor topic
Alkaloids
Alkylating Agents
Amino Acids
Animals
Anti-Bacterial Agents
Antigen-Antibody Reactions
Antilymphocyte Serum
B-Lymphocytes
Binding Sites, Antibody
Cricetinae
Dogs
Folic Acid Antagonists
Immune Tolerance
Immunologic Techniques
Lymphocyte Activation
Mice
Mitogens
Purine Nucleotides
Rabbits
Radiation Effects
Rats
Steroids
T-Lymphocytes
Thymectomy
Tranquilizing Agents

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
6235832Differential cyclophosphamide sensitivity of T lymphocytes of the dengue virus-induced suppressor pathway.Br J Exp Pathol1984https://conductscience.org/library/papers/6235832PubMed
4576753Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.Acta Diabetol Lat1972https://conductscience.org/library/papers/4576753PubMed
991462Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.Clin Exp Immunol1976https://conductscience.org/library/papers/991462PubMed
970288Comparison of the immunosuppressive efficacy of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on the primary and secondary immune response of mice to sheep erythrocytes.Agents Actions1976https://conductscience.org/library/papers/970288PubMed
769507
Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) inhibition of 19 S and 7 S plaque-forming cells in the primary and secondary immune response to sheep red blood cells by cyclophosphamide and 036.5122 (Asta).
Agents Actions1975https://conductscience.org/library/papers/769507PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4569508

GET https://conductscience.org/api/papers/v1/4569508/authors